Elinzanetant-d3
Elinzanetant-d3 (NT-814-d3) is deuterium labeled Elinzanetant. Elizanetant (NT-814) is an orally active, selective NK-1,3 receptor antagonist. Elizanetant can reduce the levels of estradiol and progesterone, and is used in the study of vascular motor symptoms and sleep disorders related to menopause in women[1][2][3].
Product Specifications
Product Name Alternative
NT-814-d3; BAY3427080-d3
UNSPSC
12352005
Target
Isotope-Labeled Compounds; Neurokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Smiles
CC(C)(C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)C(N(C2=CN=C(N3[C@@H](CN4[C@@](COCC4)([H])C3)CO)C=C2C5=C(C=C(C=C5)F)C)C([2H])([2H])[2H])=O
Molecular Formula
C33H32D3F7N4O3
Molecular Weight
671.66
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![N-[(1S)-2,3-Dihydro-1H-inden-1-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://cdn.genprice.uk/products/572/210716192614/imageurl/trc-d449885-50mg.webp)
N-[(1S)-2,3-Dihydro-1H-inden-1-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/2809R), CF740 conjugate, 0.1mg/mL
